These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 8266002
41. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Kaijser L, Pernow J, Berglund B, Lundberg JM. Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028 [Abstract] [Full Text] [Related]
42. Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure. Derchi G, Dupuis J, de Champlain J, Rouleau JL. Eur Heart J; 1993 Jan; 14(1):34-9. PubMed ID: 8432288 [Abstract] [Full Text] [Related]
47. Exercise-induced changes in plasma catecholamines and neuropeptide Y: relation to age and sampling times. Jensen EW, Espersen K, Kanstrup IL, Christensen NJ. J Appl Physiol (1985); 1994 Mar; 76(3):1269-73. PubMed ID: 8005872 [Abstract] [Full Text] [Related]
48. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig. Rudehill A, Lundberg JM, Sollevi A, Hjemdahl P. Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869 [Abstract] [Full Text] [Related]
50. Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans. Tidgren B, Theodorsson E, Hjemdahl P. Clin Physiol; 1991 Jan; 11(1):9-19. PubMed ID: 2019081 [Abstract] [Full Text] [Related]
51. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, Chalmers JP. J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722 [Abstract] [Full Text] [Related]
52. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Francis GS, Goldsmith SR, Ziesche SM, Cohn JN. Am J Cardiol; 1982 Apr 01; 49(5):1152-6. PubMed ID: 7064841 [Abstract] [Full Text] [Related]
53. Response of the beta-adrenergic system to maximal dynamic exercise in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Mäki T, Leinonen H, Näveri H, Sovijärvi A, Kontula K, Härkönen M. Am J Cardiol; 1989 Jun 01; 63(18):1348-53. PubMed ID: 2543200 [Abstract] [Full Text] [Related]
57. [Influence of amlodipine on serum level of some cytokines in patients with congestive heart failure]. Salomon P, Halawa B, Karolko B. Pol Arch Med Wewn; 2003 Feb 01; 109(2):149-55. PubMed ID: 12879778 [Abstract] [Full Text] [Related]
58. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. Bald M, Gerigk M, Rascher W. Am J Kidney Dis; 1997 Jul 01; 30(1):23-7. PubMed ID: 9214397 [Abstract] [Full Text] [Related]
59. Plasma beta-endorphin response to exercise in patients with congestive heart failure. Perna GP, Modoni S, Valle G, Stanislao M, Loperfido F. Chest; 1997 Jan 01; 111(1):19-22. PubMed ID: 8995987 [Abstract] [Full Text] [Related]
60. Circulating neuropeptide Y in humans: relation to changes in catecholamine levels and changes in hemodynamics. Hauser GJ, Danchak MR, Colvin MP, Hopkins RA, Wocial B, Myers AK, Zukowska-Grojec Z. Neuropeptides; 1996 Apr 01; 30(2):159-65. PubMed ID: 8771558 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]